Is indicated for T-cell lymphoblastic leukemia and lymphoma after failure of other treatments. Rare use is expected and will mainly be given in the outpatient setting. May be evaluated on an individual basis for inpatient use - contact pharmacy management.
Is indicated for T-cell lymphoblastic leukemia and lymphoma after failure of other treatments. Rare use is expected and will mainly be given in the outpatient setting. May be evaluated on an individual basis for inpatient use - contact pharmacy management.